DUE to the need for further
clarification on wording and
practical arrangements around the
details of the European Medicines
Agency’s (EMA) new clinical trial
data policy (PD 03 May), the
adoption of the new policy will be
delayed until Oct 2014.
The policy forces greater
transparency by proactive
publishing of clinical trial data.
Political, technical, personal data
and commercial-in-confidence
issues needed to be balanced
against proactive data disclosure
and would be worked through
before October, the EMA said.
To read more, CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 16 Jul 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Jul 14
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.